• Search products
  • Register your products
  • Basta Logbook
  • Log in
  • About BASTA
  • Contact
  • This is how BASTA works
  • Training Courses and Events
  • News
  • Notifications
  • Documents
  • Svenska
  • BASTA-product requirements
  • A quick guide to BASTA
  • Product assessment
  • BETA to BASTA
  • Building with BASTA
  • EPD in BASTA
  • Endocrine Disrupting substances
  • BASTA Competence requirements
  • Registration fee
  • Properties criteria
  • Product content
  • Product registration
  • Registration via Excel
  • Product and Company Audit
  • Two-component products
  • Product calculations
  • Chemical substances that may require deviation management
  • What do the symbols mean?
  • Procurement

Endocrine Disrupting substances

Substances approved for exemption according to the criterion 5, Endocrine disruptors, step C

Substances covered by the exemption in criterion 5 Endocrine disruptors (step C):

DPHP CAS-number 53306-54-0
DINP CAS-number 68515-48-0, 28553-12-0
DIDP CAS-number 68515-49-1, 26761-40-0

These substances are under evaluation:

DOTO, Dioctyltin oxide CAS-number 870-08-6

Products already registered containing CAS-number 870-08-6 may remain registered during the evaluation period.

Clarification exemptions

The exemption is limited to 3 years, with the possibility of extension, and may be reassessed if contradictory scientific data are presented. The step C quality control is limited to evaluating that the supplier has sufficient scientific data to support an exemption according the Basta methodology, and should not be interpreted as an assessment if the substance has an endocrine disrupting potential or not.

Substances approved for exemption are allowed for use in products registered in the Basta system according to criterion 5, provided they fulfill all other Basta criteria. The substance name, CAS number and concentration (weight%) are stated and made publicly searchable at BastaOnline for all products affected. The products are marked with an red exclamation mark in the public search function.

Guidelines and support

Guideline BASTA endocrine disruptors (2020-04-30)
Summary list with all substances covered by the criterium:
2020-11-02 Substance-list-Basta
Please note that substances related to Basta´s information
requirements are included in the file.
Properties criteria
Basta Properties criteria (2020:A2)
Beta Properties criteria (2020:A2)

Links to specified lists in step B

Danish centre list (table 8 and 13)
DK_ED-list-final_2018
Danish centre appendix
http://www.cend.dk/files/DK_ED-list-final_appendix1_2018.pdf
SIN-list
https://sinlist.chemsec.org
ECHA- CoRAP
https://echa.europa.eu/information-on-chemicals/evaluation/community-rolling-action-plan/corap-table

Methodology Endocrine Disruptors

Procedures for the assessment of endocrine disruptors in the BASTA system are based on a methodology described in the report “Guidance document for handling criteria for endocrine disruptors in the construction industry” developed by the IVL Swedish Environmental Research Institute and representatives from the construction industry.

B2369 Guidance Document Endocrine Disrupters

A transition period will be applied during the period 1/1 2020 to 1/7 2020 to adapt to the new criterion. The EDS database, which has so far been the basis for criterion 5, continues to apply until 1/7 2020, but thereafter the EDS database will only be included in the BASTA system as an information requirement.

The method is based on three steps:

A. Substances assessed as endocrine disruptors as defined by the EU *

B. Substances that are listed on three selected lists and where there are indications that the substances are endocrine disruptors or alternatively that they are being investigated within the EU.

C. The possibility of questioning the substances listed under B if there are scientifically robust arguments. Mandatory documentation requirements and approval process.

Figure 1. Decision tree for the management of endocrine disruptors.

 

In cases where step C becomes relevant, the documentation must contain:

• A summary that clarifies the substance, CAS number, in which construction products the substance is included and reasons why the substance should not be considered endocrine disruptor. Basta reserves the right to publish this summary on Basta’s website.
• A justification that addresses all arguments as to why the topic is included in one or more of the lists in step B and why these arguments are considered incorrect.
• Scientific evidence, including references to literature studies and tests, when reference is made to studies
The documentation shall be sent to: Bastaonline AB, Box 210 60, 100 31 Stockholm or via email to bastaonline@ivl.se.Basta uses expert support for evaluation of the documentation, and the cost of the evaluation is paid by the applicant – Basta provides price information on request. When requested, the substance (CAS number and chemical name), which building products the substance is included in, as well as the organization number and invoice address shall be included.

 

*) Substances should be considered to have endocrine disrupting properties if they meet all of the following criteria:

a) it shows an adverse effect in [an intact organism or its progeny]/[non-target organisms], which is a change in the morphology, physiology, growth, development, reproduction or life span of an organism, system or (sub)population  that results in an impairment of functional capacity, an impairment of the capacity to compensate for additional stress or an increase in susceptibility to other influences;
b) it has an endocrine mode of action, i.e. it alters the function(s) of the endocrine system;
c) the adverse effect is a consequence of the endocrine mode of action.

Guidance to Sustainable Construction Materials

BASTA is alone in the market to offer you freely available information about safe materials

  • About BASTA
  • Contact
  • This is how BASTA works
  • Training Courses and Events
  • News
  • Notifications
  • Documents
  • Svenska
  • Log in
  • Search products
  • Register your products
  • Basta Logbook
Street address:
Valhallavägen 81, 114 27 Stockholm
Refer taxi to:
Lindstedtsvägen 6, 114 27 Stockholm
Mail address:
BASTAonline AB
Box 210 60
100 31 Stockholm
Phone: +46 10-788 65 00
Fax: +46 10-788 65 90
bastaonline@ivl.se

© 2021 BASTA About website About cookies